Elderly mice with history of acetaminophen intoxication display worsened cognitive impairment and persistent elevation of astrocyte and microglia burden.

Autor: Catumbela CSG; Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Morales R; Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. Rodrigo.MoralesLoyola@uth.tmc.edu.; Centro Integrativo de Biologia y Quimica Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago, Chile. Rodrigo.MoralesLoyola@uth.tmc.edu.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2024 Jun 20; Vol. 14 (1), pp. 14205. Date of Electronic Publication: 2024 Jun 20.
DOI: 10.1038/s41598-024-65185-z
Abstrakt: Acetaminophen (APAP) is a leading cause of acute liver failure. The effect of APAP metabolite's effects in the periphery are well characterized; however, associated consequences in the brain remain poorly understood. Animal studies on this subject are few and reveal that frequent APAP intake can trigger cerebral abnormalities that vary depending on the subject's age. Alarmingly, experimental efforts have yet to examine associated consequences in elderly hosts, who correspond to the highest risk of medication overload, impaired drug clearance, and cognitive deficits. Here, we interrogated the cerebral and peripheral pathology of elderly mice submitted to monthly episodes of APAP intoxication since a young adult age. We found that weeks after the final episode of recurrent APAP exposure, mice exhibited worsened non-spatial memory deficit whereas spatial memory performance was unaltered. Interestingly, one month after the period of APAP intoxication, these mice showed increased glial burden without associated drivers, namely, blood-brain barrier disruption, cholesterol accumulation, and elevation of inflammatory molecules in the brain and/or periphery. Our experimental study reveals how recurrent APAP exposure affects the cognitive performance and cellular events in elderly brains. These data suggest that APAP-containing pharmacological interventions may foreshadow the elevated risk of neuropsychiatric disorders that afflict elderly populations.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: